PATENT CLAIM ANALYSIS

Application Number: 16018055
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["435", "372000"]

Abstract:
Disclosed herein is a formulation comprising an extracellular vesicle (EV), and a therapeutic active agent induced or embedded in the EV. According to preferred embodiments of the present disclosure, the EV is isolated from umbilical cord mesenchymal stem cells, and the active agent may be a growth factor, an immune-modulating agent, a small molecule, an siRNA, cDNA or a plant ingredient; for example, curcumin. Also disclosed herein are methods for producing the present formulation, and uses of the present formulation in the treatment of various diseases.

Claim (Index 15):
The method of  claim 9 , wherein the infectious disease is caused by a bacterium, virus or fungus.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.65574
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15841709', '15545937', '14825788', '14413290', '15656473']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6004184928177694
- 35 USC 102 Novelty (BERT): 0.4799418786239128
- Combined Prediction Score: 0.5883708313983838
- Mean Citation Score: 206.617044
- Max Citation Score: 218.01566
- Similarity Product: 175.78293051942944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test